Andrew Reardon

LGND

Andrew Reardon serves as officer: CLO & Secretary at Ligand Pharmaceuticals Incorporated (LGND). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

16 trades

$8.02M

Net Position

Net Seller

$8.02M

Companies Traded

LGND, LGNZZ, LGNDZ

Active Period

Mar 2023 – Jun 2026

16 total trades

Most Recent

Sell LGND

Jun 2, 2026 · $1.14M

Andrew Reardon's Insider Trading at Ligand Pharmaceuticals Incorporated (LGND)

Buys

0 · $0.00

Sells

11 · $5.74M

Total Shares Bought

Total Shares Sold

35,700

LGND Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jun 2, 2026	Sell	5,000	$227.06	$1.14M	45,891
May 4, 2026	Sell	5,000	$231.31	$1.16M	45,782
Apr 2, 2026	Sell	5,000	$201.24	$1.01M	45,922
Mar 6, 2026	Sell	4,900	$206.50	$1.01M	41,769
Jun 24, 2025	Sell	500	$114.08	$57.0K	31,903
Jun 12, 2025	Sell	500	$114.54	$57.3K	32,403
Jun 2, 2025	Sell	1,000	$104.00	$104.0K	32,903
Sep 25, 2024	Sell	2,000	$99.60	$199.2K	22,534
Aug 30, 2024	Sell	1,500	$106.39	$159.6K	22,534
May 13, 2024	Sell	10,000	$83.04	$830.4K	22,205
Mar 28, 2023	Sell	300	$69.92	$21.0K	16,308

Andrew Reardon's Insider Trading at LIGAND PHARMS BETA CVR (LGNZZ)

Buys

0 · $0.00

Sells

1 · $1.78M

Total Shares Bought

Total Shares Sold

9,680

LGNZZ Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Feb 14, 2026	Sell	9,680	$183.83	$1.78M	0

Andrew Reardon's Insider Trading at LIGAND PHARMS INC CVR (LGNDZ)

Buys

0 · $0.00

Sells

4 · $507.0K

Total Shares Bought

Total Shares Sold

4,222

LGNDZ Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value
Aug 10, 2025	Sell	1,325	$150.06	$198.8K
Jun 23, 2025	Sell	500	$114.08	$57.0K
Jun 10, 2025	Sell	500	$114.54	$57.3K
Aug 10, 2024	Sell	1,897	$102.18	$193.8K

Related Insiders

LAMATTINA JOHN L

Director

LGNDSell · Jun 12, 2026

Jason Aryeh

Director

LGNDSell · Jun 12, 2026

KOZARICH JOHN W

Director

LGNDSell · May 14, 2026

Stephen L Sabba

director

LGNDSell · Mar 25, 2026

Octavio Espinoza

officer: Chief Financial Officer

LGNDSell · Mar 13, 2026

Octavio Espinoza

Chief Financial Officer

LGNZZSell · Feb 14, 2026

Todd C Davis

Chief Executive Officer

LGNZZSell · Feb 14, 2026

KOZARICH JOHN W

Director

LGNDZSell · Feb 2, 2026

Explore More Insider Trading Data

LGND Insider Trading Activity

View all insider trades at Ligand Pharmaceuticals Incorporated

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity